Cargando…
Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case o...
Autores principales: | Liyanage, I.K., Niriella, M.A., de Silva, A.P., de Silva, N., de Silva, H.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722334/ https://www.ncbi.nlm.nih.gov/pubmed/31616760 http://dx.doi.org/10.14309/crj.0000000000000075 |
Ejemplares similares
-
Rheumatic Adenitis
por: DeSilva, George
Publicado: (1921) -
Hail the Dermato-Trichologist!
por: Yesudian, Patrick
Publicado: (2014) -
Adenitis, Acute and Chronic
por: Larzelere, J. R.
Publicado: (1878) -
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019) -
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report
por: Niriella, Madunil A., et al.
Publicado: (2016)